NAD+ has become the headline molecule of the longevity industry — sold as IV drips in wellness clinics and as precursor supplements promising energy, sharper thinking and slower ageing. The underlying biology is genuinely fascinating. The human evidence, however, is still early, and the marketing has comfortably overtaken it. Here is the honest picture.

What NAD+ actually is

Nicotinamide adenine dinucleotide — NAD+ — is a coenzyme found in every cell of your body. It is essential for converting food into usable energy and acts as a fuel for enzymes involved in DNA repair and cellular stress responses, including the sirtuins that feature heavily in ageing research. None of this is controversial; NAD+ is foundational biochemistry.

The longevity interest comes from a consistent observation: NAD+ levels appear to decline with age in many tissues, and in animal models, restoring them improves various markers of metabolic and cellular health. The leap the industry has made is to assume the same is true — and meaningful — in humans. That part is still being tested.

One technical point explains a great deal of the market. NAD+ itself is poorly absorbed when swallowed, which is why the supplement industry sells precursors your body can convert, and why clinics offer it intravenously instead. Neither route changes the underlying question: does raising NAD+ actually improve health outcomes in people? Raising a blood marker and improving a life are not the same achievement.

What human research actually shows

Precursor supplements

Most human studies use oral precursors — nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) — rather than NAD+ itself. Randomised trials show these can raise NAD+ levels in blood, and they appear reasonably well tolerated over the study periods used. What trials have largely not yet shown is consistent, clinically meaningful improvement in the outcomes people actually care about: energy, body composition, cognition or lifespan. Some small studies report encouraging signals on certain metabolic or vascular markers; others find little effect. In short, the research is promising, early and unfinished.

IV NAD+ drips

Intravenous NAD+ is where the gap between marketing and evidence is widest. Published controlled trials of IV NAD+ in healthy people are scarce, and the dramatic claims attached to drip lounges — rapid anti-ageing, detoxification, transformation of energy — are not supported by the current literature. Infusions are also expensive, time-consuming and commonly cause unpleasant effects such as flushing, nausea or chest tightness when run quickly. A higher price and a cannula do not make a therapy more proven.

Questions of risk and unknowns

Short-term tolerability of oral precursors looks acceptable in trials, but long-term safety data in humans is limited, and there are open scientific questions — including how chronically elevating NAD+ pathways behaves across different tissues over years. There is also very little research specific to women across the hormonal lifespan: pregnancy, breastfeeding, perimenopause and beyond. Absence of evidence of harm is not the same as evidence of safety.

  • Supplement-market products vary in quality; independent verification matters.
  • Anyone with a medical condition or on medication needs individual advice, not a wellness menu.
  • Cost is a real consideration — the monthly spend on drips would fund a great deal of proven health investment.
  • Marketing language such as “clinically proven” often refers to the marker change, not to any benefit you would feel.

The grounded conclusion

NAD+ biology is worth watching, and the next decade of trials may clarify whether precursors earn a place in healthy ageing. But today, the interventions proven to support mitochondrial health and energy in midlife women are the familiar ones: progressive strength training, regular cardiovascular work, adequate protein, good sleep and not smoking. Exercise itself is one of the most reliable known stimulators of the body’s own NAD+ machinery. If you are still curious about supplementation, take that curiosity to a qualified clinician who can review your health history and the current evidence with you.

Important: This article is educational only and is not medical advice. Human research on NAD+ precursors is early, long-term safety is not established, and IV NAD+ marketing currently runs ahead of the published evidence. The DB Coaching Method does not sell or recommend NAD+ products. Always speak to a qualified clinician before considering any supplement, peptide or therapy — particularly if you are pregnant, breastfeeding, on medication or managing a health condition.

Train with a coach who understands female physiology.

The DB Method Coaching focuses your energy on what the evidence rewards — private, structured strength and conditioning for women in Dubai and online.

Apply privately